Literature DB >> 16501930

Management of cerebral vasospasm.

R Loch Macdonald1.   

Abstract

Cerebral vasospasm is delayed narrowing of the large arteries of the circle of Willis occurring 4 to 14 days after aneurysmal subarachnoid hemorrhage (SAH). It is but one cause of delayed deterioration after SAH but, in general, is the most important potentially treatable cause of morbidity and mortality after SAH. Development of vasospasm is best predicted by the volume, location, persistence and density of subarachnoid clot early after SAH. Diagnosis is made by catheter angiography or, with less accuracy, by computed tomographic angiography, transcranial Doppler ultrasound or other methods. Treatment remains problematic because it is expensive, time-consuming, associated with substantial risk and largely ineffective. Treatment includes optimization of factors that affect cerebral blood flow and metabolism, systemic administration of nimodipine, hemodynamic therapy and pharmacologic and mechanical angioplasty.

Entities:  

Mesh:

Year:  2006        PMID: 16501930     DOI: 10.1007/s10143-005-0013-5

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  121 in total

1.  Arteriographic demonstration of spasm of the intracranial arteries, with special reference to saccular arterial aneurysms.

Authors:  A ECKER; P A RIEMENSCHNEIDER
Journal:  J Neurosurg       Date:  1951-11       Impact factor: 5.115

2.  Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa.

Authors:  G Lanzino; N F Kassell; N W Dorsch; A Pasqualin; L Brandt; P Schmiedek; L L Truskowski; W M Alves
Journal:  J Neurosurg       Date:  1999-06       Impact factor: 5.115

3.  Vasospasm in monkeys resolves because of loss of and encasement of subarachnoid blood clot.

Authors:  Z D Zhang; B Yamini; T Komuro; S Ono; L Johns; L S Marton; B Weir; R L Macdonald
Journal:  Stroke       Date:  2001-08       Impact factor: 7.914

4.  Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study.

Authors:  Peter Vajkoczy; Bernhard Meyer; Stefan Weidauer; Andreas Raabe; Claudius Thome; Florian Ringel; Volker Breu; Peter Schmiedek
Journal:  J Neurosurg       Date:  2005-07       Impact factor: 5.115

5.  Neurologic complications of cerebral angiography. A retrospective study of complication rate and patient risk factors.

Authors:  A M Leffers; A Wagner
Journal:  Acta Radiol       Date:  2000-05       Impact factor: 1.990

6.  Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion.

Authors:  Alejandro A Rabinstein; Mark A Pichelmann; Jonathan A Friedman; David G Piepgras; Douglas A Nichols; Jon I McIver; L Gerard Toussaint; Robyn L McClelland; Jimmy R Fulgham; Fredric B Meyer; John L D Atkinson; Eelco F Wijdicks
Journal:  J Neurosurg       Date:  2003-02       Impact factor: 5.115

7.  Time course of vasospasm in man.

Authors:  B Weir; M Grace; J Hansen; C Rothberg
Journal:  J Neurosurg       Date:  1978-02       Impact factor: 5.115

8.  Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.

Authors:  N F Kassell; E C Haley; C Apperson-Hansen; W M Alves
Journal:  J Neurosurg       Date:  1996-02       Impact factor: 5.115

9.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Authors:  G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou
Journal:  N Engl J Med       Date:  1983-03-17       Impact factor: 91.245

10.  Cerebrovascular reactivity in patients with ruptured intracranial aneurysms.

Authors:  B Voldby; E M Enevoldsen; F T Jensen
Journal:  J Neurosurg       Date:  1985-01       Impact factor: 5.115

View more
  25 in total

1.  Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm.

Authors:  Elisa R Zanier; Giovanna Brandi; Giuseppe Peri; Luca Longhi; Tommaso Zoerle; Mauro Tettamanti; Cecilia Garlanda; Anna Sigurtà; Serenella Valaperta; Alberto Mantovani; Maria Grazia De Simoni; Nino Stocchetti
Journal:  Intensive Care Med       Date:  2010-11-12       Impact factor: 17.440

2.  Outcomes-based assessment of a new reference standard for delayed cerebral ischemia related to vasospasm in aneurysmal subarachnoid hemorrhage.

Authors:  Pina C Sanelli; Nikesh Anumula; Rachel Gold; Elliott Elias; Carl Johnson; Joseph Comunale; Apostolos J Tsiouris; Alan Z Segal
Journal:  Acad Radiol       Date:  2012-06-23       Impact factor: 3.173

3.  Validation of a new reference standard for the diagnosis of vasospasm.

Authors:  Melissa Reichman; Rachel Gold; Edward Greenberg; Jana Ivanidze; Elliot Elias; Joseph Comunale; Apostolos J Tsiouris; Carl Johnson; Pina C Sanelli
Journal:  Acad Radiol       Date:  2010-06-12       Impact factor: 3.173

4.  Controversies and evolving new mechanisms in subarachnoid hemorrhage.

Authors:  Sheng Chen; Hua Feng; Prativa Sherchan; Damon Klebe; Gang Zhao; Xiaochuan Sun; Jianmin Zhang; Jiping Tang; John H Zhang
Journal:  Prog Neurobiol       Date:  2013-09-25       Impact factor: 11.685

Review 5.  Diagnosis of cerebral vasospasm and risk of delayed cerebral ischemia related to aneurysmal subarachnoid haemorrhage: an overview of available tools.

Authors:  Susanna Bacigaluppi; Gianluigi Zona; Francesca Secci; Gianantonio Spena; Nicola Mavilio; Giulia Brusa; Ronit Agid; Timo Krings; Gianandrea Ottonello; Marco Fontanella
Journal:  Neurosurg Rev       Date:  2015-03-04       Impact factor: 3.042

6.  Improvement in angiographic cerebral vasospasm after intra-arterial verapamil administration.

Authors:  J V Sehy; W E Holloway; S-P Lin; D T Cross; C P Derdeyn; C J Moran
Journal:  AJNR Am J Neuroradiol       Date:  2010-08-12       Impact factor: 3.825

7.  Preconditioning the human brain: practical considerations for proving cerebral protection.

Authors:  Sebastian Koch
Journal:  Transl Stroke Res       Date:  2010-09       Impact factor: 6.829

8.  Intra-arterial colforsin daropate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage.

Authors:  Satoshi Suzuki; Osamu Ito; Tetsuro Sayama; Katsuya Goto
Journal:  Neuroradiology       Date:  2009-12-02       Impact factor: 2.804

9.  Inhibition of cerebral vasoconstriction by dantrolene and nimodipine.

Authors:  Salvatore Salomone; Guray Soydan; Michael A Moskowitz; John Randall Sims
Journal:  Neurocrit Care       Date:  2008-10-16       Impact factor: 3.210

10.  The costs and prognostic characteristics of ischaemic neurological deficit due to subarachnoid haemorrhage in the United Kingdom. Evidence from the MRC International Subarachnoid Aneurysm Trial.

Authors:  Oliver Rivero-Arias; Jane Wolstenholme; Alastair Gray; Andrew J Molyneux; Richard S C Kerr; Julia A Yarnold; Mary Sneade
Journal:  J Neurol       Date:  2009-02-09       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.